alpha-L-Fucp-(1->3)-[beta-D-Galp-(1->4)]-D-GlcpNAc

Term ID

CHEBI:62287

Synonyms

(Gal)1 (GlcNAc)1 (LFuc)1
3-FL
3-Fucosyllactosamine
6-deoxy-alpha-L-galactopyranosyl-(1->3)-[beta-D-galactopyranosyl-(1->4)]-2-acetamido-2-deoxy-D-glucopyranose
alpha-L-Fuc-(1->3)-[beta-D-Gal-(1->4)]-D-GlcNAc
alpha-L-fucopyranosyl-(1->3)-[beta-D-galactopyranosyl-(1->4)]-2-(acetylamino)-2-deoxy-D-glucopyranose
alpha-L-fucopyranosyl-(1->3)-[beta-D-galactopyranosyl-(1->4)]-2-acetamido-2-deoxy-D-glucopyranose
alpha-L-fucosyl-(1->3)-[beta-D-galactosyl-(1->4)]-N-acetyl-D-glucosamine
alpha-L-Fucp-(1->3)-[beta-D-Galp-(1->4)]-D-GlcpNAc
beta-D-Gal-(1->4)-[alpha-L-Fuc-(1->3)]-D-GlcNAc
beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-D-glucosamine
Galbeta1-4(Fucalpha1-3)GlcNAc
Le(x)
Lewis x antigen
Lewis(x)
Tetraantennary neutral lactosaminoglycan
WURCS=2.0/3,3,2/[a2122h-1x_1-5_2*NCC/3=O][a1221m-1a_1-5][a2112h-1b_1-5]/1-2-3/a3-b1_a4-c1

Definition

An amino trisaccharide consisting of N-acetylglucosamine having a fucosyl residue attached at the 3-position via an alpha-linkage and a galactosyl residue attached at the 4-position via a beta-linkage.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: amino trisaccharide glucosamine oligosaccharide

amino trisaccharide glucosamine oligosaccharide Show first 5 Terms
has subtype: alpha-L-Fucp-(1->3)-[beta-D-Galp-(1->4)]-beta-D-GlcpNAc

alpha-L-Fucp-(1->3)-[beta-D-Galp-(1->4)]-beta-D-GlcpNAc Show first 5 Terms
has_role: antigen epitope

antigen epitope Show first 5 Terms
inverse has_functional_parent: alpha-L-Fucp-(1->3)-[alpha-L-Fucp-(1->3)-beta-D-Galp-(1->4)]-D-GlcpNAc

alpha-L-Fucp-(1->3)-[alpha-L-Fucp-(1->3)-beta-D-Galp-(1->4)]-D-GlcpNAc Show first 5 Terms
inverse is_substituent_group_from: beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-D-glucosaminyl group

beta-D-galactosyl-(1->4)-[alpha-L-fucosyl-(1->3)]-N-acetyl-D-glucosaminyl group Show first 5 Terms

Phenotype

Phenotype resulting from alpha-L-Fucp-(1->3)-[beta-D-Galp-(1->4)]-D-GlcpNAc

Phenotype where environments contain alpha-L-Fucp-(1->3)-[beta-D-Galp-(1->4)]-D-GlcpNAc

Phenotype modified by environments containing alpha-L-Fucp-(1->3)-[beta-D-Galp-(1->4)]-D-GlcpNAc

Human Disease Model